This indicated that inhaled budesonide increased lung inflammation, reduced the clearance of P. aeruginosa, and increased the severity of pulmonary infection in OVA-challenged mice exposed to P. aeruginosa. Infection with P. aeruginosa was associated with increased levels of IL-4 in OVA-challenged mice treated with budesonide. The gene discussed is IL4; the disease is infection.